Incidence and predictors of diabetic retinopathy among patients with type 2 diabetes and hypertension: a 10-year retrospective follow-up study

Sci Rep. 2026 May 16. doi: 10.1038/s41598-026-53165-4. Online ahead of print.ABSTRACTDiabetes-related blindness creates a major challenge for the healthcare system due to its high treatment cost. The presence of type 2 diabetes has been associated with an increased risk of hypertension, and vice ver

Lessons from Discover-NOW programme: Transforming chronic kidney disease care in North West London

No abstractAnn Acad Med Singap. 2026 May 5. doi: 10.47102/annals-acadmedsg.2025471. Online ahead of print.NO ABSTRACTPMID:42142320 | DOI:10.47102/annals-acadmedsg.2025471

Treatment Persistence with Combination Eye Drops for Glaucoma: A Longitudinal Analysis Using Japanese Medical Claims Data

Ophthalmol Ther. 2026 May 15. doi: 10.1007/s40123-026-01384-3. Online ahead of print.ABSTRACTINTRODUCTION: Glaucoma is a chronic progressive disease and the leading cause of blindness, particularly among older individuals. Treatment persistence with intraocular pressure (IOP)-lowering therapy is ess

Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons

Adv Ther. 2026 May 15. doi: 10.1007/s12325-026-03614-3. Online ahead of print.ABSTRACTINTRODUCTION: C3 glomerulopathy (C3G) is a rare complement-mediated kidney disease. Pegcetacoplan [targeted complement 3 (C3)/C3b inhibitor] and iptacopan (factor B inhibitor) target the complement system and are a

Shared Decision-Making Preferences of Black Men With Hypertension in the United States Mid-South: A Qualitative Study

J Cardiovasc Nurs. 2026 May 15. doi: 10.1097/JCN.0000000000001311. Online ahead of print.ABSTRACTBACKGROUND: Black men in the United States face disproportionately high rates of uncontrolled hypertension, contributing to premature mortality. Effective blood pressure control depends on high-quality a

Clinical Characteristics and Management Outcomes of Severe Multi-Valvular Rheumatic Heart Disease: A Hospital-Based Analysis

Cureus. 2026 Apr 13;18(4):e106946. doi: 10.7759/cureus.106946. eCollection 2026 Apr.ABSTRACTBACKGROUND: Multi-valvular involvement represents the most severe form of rheumatic heart disease (RHD), presenting complex clinical challenges requiring a comprehensive understanding for optimal patient mana

Improving Hypertension Control through a Standardized Workflow at the University of Kansas SOM-Wichita Department of Internal Medicine Clinic

Kans J Med. 2026 Apr 22;19(Suppl 1):26. doi: 10.17161/kjm.vol19.25395. eCollection 2026 Mar-Apr.ABSTRACTINTRODUCTION: Uncontrolled hypertension remains a leading cause of preventable cardiovascular morbidity and mortality. Despite frequent clinic visits, timely follow-up for elevated blood pressure

Probable case of anaphylaxis due to hydrocortisone in a septic shock patient

Ther Adv Drug Saf. 2026 May 10;17:20420986261443460. doi: 10.1177/20420986261443460. eCollection 2026.ABSTRACTWe present a case of probable anaphylactic shock induced by intravenous hydrocortisone in a 72-year-old male patient with septic shock. The patient, admitted for management of infected press

Is the Cardiovascular Risk Increased in Patients with Isolated Systolic Hypertension and Anemia?

Curr Vasc Pharmacol. 2026 May 8. doi: 10.2174/0115701611427759260410142243. Online ahead of print.ABSTRACTINTRODUCTION: Isolated systolic hypertension (ISH) is important because of its very high prevalence. Anemia is also a highly prevalent non-communicable disease. The paper aims to answer the stud

Advances in targeted pharmacotherapies for pulmonary hypertension associated with left heart disease

Zhonghua Yi Xue Za Zhi. 2026 May 19;106(18):1762-1766. doi: 10.3760/cma.j.cn112137-20260210-00447.ABSTRACTPulmonary hypertension associated with left heart disease (PH-LHD) represents the most prevalent form of pulmonary hypertension. The concomitant elevation in pulmonary arterial pressure signific

Safety net primary care for emergency physicians: Diagnosis and treatment of asymptomatic hypertension

Am J Emerg Med. 2026 May 7;107:21-25. doi: 10.1016/j.ajem.2026.05.012. Online ahead of print.ABSTRACTHypertension is a major modifiable risk factor for cardiovascular disease. Asymptomatic hypertension is a common presenting chief concern and incidentally noted vital sign abnormality in the emergenc

Evaluation of Risk Factors for Postoperative Infection in 176 Patients Undergoing Laparoscopic Cholecystectomy at a Single Center

Med Sci Monit. 2026 May 14;32:e952229. doi: 10.12659/MSM.952229.ABSTRACTBACKGROUND Laparoscopic cholecystectomy (LC) has become the standard minimally invasive treatment for benign gallbladder diseases worldwide; however, postoperative infections remain a clinically significant complication requirin

Leveraging Interleukin-1 Blockade as a Therapeutic Strategy for Cardiac Sarcoidosis: Rationale and Design for the RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS)

J Card Fail. 2026 May;32(5):877-887. doi: 10.1016/j.cardfail.2026.03.010.ABSTRACTCardiac sarcoidosis (CS) is an inflammatory condition characterized by granuloma formation that can lead to life-threatening arrhythmias and heart failure. Although corticosteroids have long been the mainstay of treatme

Diagnostic and management dilemmas in pulmonary hypertension

Eur Respir Rev. 2026 May 13;35(180):250337. doi: 10.1183/16000617.0337-2025. Print 2026 Apr.ABSTRACTINTRODUCTION: Although current international guidelines provide comprehensive evidence-based guidance for the management of pulmonary hypertension, clinicians are still regularly faced with uncertaint

Challenges and Strategies in Managing Pulmonary Arterial Hypertension Within the Indian Healthcare System: A Consensus Statement From the Pulmonary Vascular Research Institute India Taskforce

Pulm Circ. 2026 May 11;16:e70311. doi: 10.1002/pul2.70311. eCollection 2026 Jun.ABSTRACTPulmonary arterial hypertension (PAH) in India is a substantial yet under-recognized contributor to cardiovascular morbidity and mortality. Its progressive course, nonspecific early manifestations, and heterogene

Hypertension Prevalence, Risk Factors, and Care Cascade Among Nursing Staff at The Largest Tertiary-Care Hospital, Western Gujarat: A Cross-Sectional Study

Indian J Community Med. 2026 Mar-Apr;51(2):314-320. doi: 10.4103/ijcm.ijcm_632_24. Epub 2025 Nov 20.ABSTRACTBACKGROUND: Hypertension is the most common risk factor for noncommunicable diseases and is a major global public health challenge due to its very high prevalence, which leads to significant r

Hidden Burden of Hypertension in Turkiye: A Multi-Center DAHUDER World Hypertension Day Study Reveals Gaps in Awareness, Adherence, and Control

J Clin Med. 2026 May 6;15(9):3535. doi: 10.3390/jcm15093535.ABSTRACTBackground: Hypertension remains the single most important modifiable risk factor for cardiovascular disease, stroke, and premature mortality worldwide. Despite major pharmacological advances, awareness, treatment, and control rates

Prevalence, clinical characteristics and management of low-renin hypertension: a real-world cohort study

J Hum Hypertens. 2026 May 12. doi: 10.1038/s41371-026-01148-3. Online ahead of print.ABSTRACTEmerging evidence suggests that patients with low-renin hypertension (LRH) benefit from targeted treatment with mineralocorticoid receptor antagonists (MRA). With broader screening for primary aldosteronism

Single Anastomosis Sleeve Ileal Bypass Could Be the Future of Redo Surgery? A Single-Center Cohort Study

J Laparoendosc Adv Surg Tech A. 2026 May 12:10926429261449962. doi: 10.1177/10926429261449962. Online ahead of print.ABSTRACTBACKGROUND: Obesity is a leading global health challenge associated with increased morbidity and mortality from cardiovascular disease, type 2 diabetes, hypertension (HTN), an

Exploring the social and behavioral barriers to hypertension self-care among indonesian adults: a qualitative study based on the theory of planned behavior

BMC Public Health. 2026 May 11. doi: 10.1186/s12889-026-27470-6. Online ahead of print.ABSTRACTBACKGROUND: Sustaining hypertension self-care practices presents ongoing challenges, particularly in socially complex and resource-limited settings. Although the Theory of Planned Behavior (TPB) is widely

Gap between guidelines and practice: echocardiography reporting in neonatal pulmonary hypertension

Cardiol Young. 2026 May 11:1-6. doi: 10.1017/S104795112611292X. Online ahead of print.ABSTRACTObjectives: Targeted neonatal echocardiography is increasingly integrated into neonatal care and plays a crucial role in the evaluation and management of persistent pulmonary hypertension of the newborn. Th

Associations between hypertension care cascade, cognitive function, and cardiovascular disease in middle-aged and older adults: the exacerbated role of social isolation

Clin Hypertens. 2026 May 1;32:e23. doi: 10.5646/ch.2026.32.e23. eCollection 2026.ABSTRACTBACKGROUND: The role of social isolation in the connections between the hypertension care cascade, cognitive function, and cardiovascular disease (CVD) remains unclear. This study aims to investigate the relatio

ADHERENCE TO PHARMACOTHERAPY STANDARDS FOR CHRONIC CARDIOVASCULAR AND RESPIRATORY DISEASES AMONG PRIMARY CARE PHYSICIANS IN THE SAMARKAND REGION

Georgian Med News. 2026 Mar;(372):48-54.ABSTRACTBACKGROUND: Guideline-based pharmacotherapy for chronic cardiovascular diseases and chronic respiratory diseases is a key determinant of outcomes in primary care; however, adherence may vary across territories due to organizational factors and access t

Blood pressure below target levels in treated older patients with hypertension: prevalence and associated factors

Rev Esp Cardiol (Engl Ed). 2026 May 8:S1885-5857(26)00102-7. doi: 10.1016/j.rec.2026.03.011. Online ahead of print.ABSTRACTINTRODUCTION AND OBJECTIVES: European hypertension guidelines recommend avoiding treatment targets of systolic blood pressure (BP) < 120 mmHg or diastolic BP < 70 mmHg. This stu